On November 19, 2018, the board of directors of Odonate Therapeutics, Inc. promoted John G. Lemkey, who previously served as Chief Financial Officer, to Chief Operating Officer and Michael S. Hearne, who previously served as Vice President of Finance and Accounting, to Chief Financial Officer. Effective on Mr. Hearne's promotion, the board of directors appointed Mr. Hearne to serve as the company's principal financial officer and principal accounting officer. Mr. Hearne succeeds Mr. Lemkey in those roles.

Mr. Lemkey, including a biographical summary, is included in the company's definitive proxy statement for the 2018 Annual Meeting of Stockholders on Schedule 14A filed with the U.S. Securities and Exchange Commission on June 1, 2018.